IVTY Invuity Inc

INVESTOR ALERT: Investigation of Invuity Announced by Holzer & Holzer

Holzer & Holzer, LLC is investigating whether certain statements issued by Invuity, Inc. (“Invuity” or the “Company”) (NASDAQ: IVTY) complied with federal securities laws. After the markets closed on November 3, 2016, Invuity announced its financial results for the third quarter of 2016 and lowered its guidance. The price of Invuity stock fell significantly following the news.

If you purchased Invuity common stock before November 4, 2016 and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at [email protected] or Marshall P. Dees, Esq. at [email protected], or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

EN
21/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Invuity Inc

 PRESS RELEASE

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corpo...

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million. "The combination of Stryker's establi...

 PRESS RELEASE

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal...

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies. PhotonGuide Adapt represents a new platform for Invui...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter, Six-Month Financial Results

Invuity Announces 2018 Second Quarter, Six-Month Financial Results SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights Second quarter 2018 revenue grew 7.5% to $10.5 million compared to revenue of $9.8 million in the second quarter of 2017.Disposable revenue in the second quarter of 2018 grew 11.5% to $9.2 million compared to $8.3 million in the second quarter of 2017.Net loss for the second q...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter Financial Results and Conference...

Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results and other busine...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch